10 diciembre 2014
Promising results from a novel therapeutic approach for women with estrogen-receptor-positive breast cancer have been reported by scientists. The new approach, a new drug class called gamma secretase inhibitors (GSI), specifically inhibits Notch and shuts down critical genes and cancer cells responsible for tumor growth.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/ZnddnilyaLs/141210162105.htm
